People with type 2 diabetes must develop certain life habits to monitor your levels of blood glucose. That is, you must perform a series of activities practically mandatory to regulate the values of blood sugar.
Some of these habits are changes in diet, a less sedentary lifestyle, use of insulin or specific medications for people with diabetes. Furthermore, this disease affects almost 10% of the world’s population.
Now, a study conducted by the Medical Center of the University of Maryland Midtown Campus in Baltimore and published in the ‘Journal of Clinical Endocrinology & Metabolism’ targets antacids as a way to improve blood glucose levels.
Relationship of antacids and diabetes
According to this research work, antacids help improve glycemic control in people with diabetes. However, this same study determines that its consumption does not cause any reduction in the risk of diabetes for the general population.
Carol Chiung-Hui Peng, one of the lead authors of this study, notes that “our research showed that the prescription of antacids as an adjunct to standard care was superior to standard therapy in lowering hemoglobin A1c (HbA1c) levels. and fasting blood sugar in people with diabetes. ‘
For his part, Dr. Huei-Kai Huang, from the Hualien Tzu Chi Hospital in Hualien (Taiwan), states that “in the case of people without diabetes, taking antacids did not significantly alter the risk of developing the disease.”
Analysis for glycemic control
With all this, the researchers carried out a meta-analysis regarding the effects of proton pump inhibitors (PPIs) on the blood glucose levels of people with diabetes. Thus, the objective was to determine if this type of medication could prevent the appearance of diabetes in the general population.
This detailed analysis consisted of seven studies for glycemic control and 5 studies linked to the risk of incident diabetes.
In this sense, the researchers found that antacids can reduce HbA1c levels by 0.36% in people with diabetes and minimize fasting blood glucose by 10 mg / dl, according to the results of seven clinical trials.
One of the negative aspects is that the results showed that antacids do not cause any effect in reducing the risk of developing diabetes in people who do not have this disease.
Finally, Dr. Kashif Munir of the University of Maryland School of Medicine argues that “people with diabetes should know that these commonly used antacid medications can improve glycemic control, and providers might consider this glucose-lowering effect when prescribing these drugs to their patients.